As part of our ongoing series here at The Acquirer’s Multiple, we provide this feature article titled ‘Stock in Focus‘ where we focus on one of the stocks from our Stock Screeners.
One of the cheapest stocks in our Stock Screeners is:
Abbott Laboratories (ABT)
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
A quick look at the share price history (below) over the past twelve months shows that the price is down 17.26%. Here’s why the company is undervalued.
Market Cap: $172 Billion
Enterprise Value: $179 Billion
Operating Earnings: $10.3 Billion
Acquirer’s Multiple: 17.50
Free Cash Flow (TTM)
Free Cash Flow: $8.47 Billion
FCF/EV Yield: 4.92
Shareholder Yield: 4%
Altman Z-Score: 4.98
ROA (5 Year Avge%): 14
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple: